Evidence map›Paper›PMID 42353648›Full record

ArticleCurrent issues in molecular biology2026

Correction: Wang et al. Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer.

Li Wang, Yaoxing Wang, Mingkai Shao, Tao Wang, Wanbao Zheng, Jun Cao, Renwen Luo, Youyan Tu, Yiting Xia, Yiming Wei and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Li WangCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.
Yaoxing WangCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.
Mingkai ShaoCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.
Tao WangSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Wanbao ZhengSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Jun CaoSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Renwen LuoSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Youyan TuSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Yiting XiaCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.
Yiming WeiCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.
Ning LiuSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Wenjie LuSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.ORCID 0000-0003-1741-2311
Youzhi XuCollege of Basic Medicine, Anhui Medical University, Hefei 230032, China.ORCID 0000-0003-2160-7576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID42353648
PMCPMC13298312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.